CGRP receptor antagonists: A new frontier of anti-migraine medications

Overview of attention for article published in Drug Discovery Today: Therapeutic Strategies, December 2006

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#2 of 115)
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news: 1 news outlet
twitter: 1 X user

patent: 50 patents

Readers on

mendeley: 46 Mendeley

So far, Altmetric has seen 50 patents that reference this research output.

Treatment of headache using anti-CGRP antibodies hereof

Grant US-12630614-B2

United States of America

19 May 2026

Acute treatment and rapid treatment of headache using anti-CGRP antibodies

Grant US-12391749-B2

United States of America

19 Aug 2025

Treatment of headache using anti-CGRP antibodies

Grant US-12384836-B2

United States of America

12 Aug 2025

Treatment of most bothersome symptom (MBS) associated with migraine using anti-CGRP…

Grant US-12384837-B2

United States of America

12 Aug 2025

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 46 additional patents.